Our state-of-the-art facility is designed and built to meet highest FDA and EMA GMP requirements globally. Alvotech’s primary focus is on safety, compliance and flexibility. We strive to combine development with clinical and commercial demands for many products and to meet the needs of customers both today and for many years to come.

Our operations are fully integrated, with drug substance, drug products and quality control testing and release within the same location, to support a lean and efficient flow. We are using single use technology to minimize cleaning validation and product changes over time.

Biosimilars in production

Manufacturing and in-house R&D.

Key facts

  • One of the newest facilities in the industry for R&D, API manufacturing and filling of biopharmaceuticals
  • 13,278 square meters facility and laboratories, including 2500 square meters of office space
  • Proven high yield fermentation and downstream process
  • Aseptic filling and finishing lines for vials and prefilled syringes
  • cGMP manufacturing capacity for clinical and commercial scale facility
    FDA/EMA GMP standards
  • High throughput R&D capabilities and development suite


The treatment of millions of patients around the world depends on the safe and reliable production of high-quality medicines.

Significant commitment, skills and experience are vital to ensure the quality of our medicines and a robust quality control and reliable supply of medicines to our customers and partners around the globe are the cornerstone of our business.

Quality is a philosophy which Alvotech embraces in every step of its integrated process.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.